Safety Profile of Resmetirom: A Real-World Study Based on FAERS Database

不良事件报告系统 医学 药物警戒 不利影响 上市后监督 置信区间 优势比 预警系统 急诊医学 泊松回归 安全监测 数据库 内科学 可能性 预警系统 食品药品监督管理局 安全概况 贝叶斯概率 逻辑回归 重症监护医学 病历 禁忌症 患者安全 假阳性悖论 单变量 风险评估 数据挖掘 医学名词 梅德林 退出时间 事件(粒子物理)
作者
Qiang Zheng,Yihan Wang,Chunling Zhang
出处
期刊:Hospital Pharmacy [SAGE Publishing]
卷期号:: 00185787261496811-00185787261496811
标识
DOI:10.1177/00185787261496811
摘要

Objective: To systematically evaluate adverse event reporting patterns and potential safety signals associated with resmetirom using the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS). Methods: FAERS reports from the first quarter of 2024 through the second quarter of 2026 were analyzed. Adverse events associated with resmetirom were coded using the Medical Dictionary for Regulatory Activities and evaluated at the Preferred Term (PT) and System Organ Class (SOC) levels. Signal detection was performed using the reporting odds ratio, proportional reporting ratio, Bayesian Confidence Propagation Neural Network, and Multi-item Gamma Poisson Shrinker. A signal was considered positive only when all 4 algorithms met their predefined criteria. Time-to-onset patterns were further assessed using Weibull distribution analysis. Results: A total of 2035 resmetirom-related reports were identified. The most frequently reported adverse events included diarrhea, nausea, pruritus, fatigue, and increased alanine aminotransferase. Positive PT-level signals were observed across gastrointestinal, hepatobiliary, laboratory, and thyroid-related events, including diarrhea, nausea, abdominal pain, hepatotoxicity, suspected drug-induced liver injury, cholelithiasis, and abnormalities in thyroid function tests. At the SOC level, investigations and hepatobiliary disorders met all 4 signal detection criteria. Among 220 reports with valid onset information, the median time to onset was 14.5 days (interquartile range, 1.5-60.5 days). The Weibull shape parameter was 0.60 (95% CI, 0.54-0.67), indicating an early failure pattern. Conclusions: This postmarketing pharmacovigilance study largely reinforced the known gastrointestinal, hepatic, gallbladder, and thyroid-related safety profile of resmetirom while identifying additional reporting signals that warrant further investigation. Adverse events tended to be reported early after treatment initiation, supporting closer monitoring during the initial treatment period. These findings should be interpreted as disproportionality signals rather than evidence of incidence or causality and require validation in longitudinal real-world studies.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
无花果的应助被科研一路绿灯采纳,获得10
1秒前
查找发布了新的文献求助20
2秒前
奶茶电竞精神完成签到,获得积分10
3秒前
老实人完成签到,获得积分10
5秒前
浮生发布了新的文献求助10
5秒前
Unstoppable完成签到,获得积分10
5秒前
嗯哼完成签到 ,获得积分10
5秒前
高大河马发布了新的文献求助10
6秒前
标致的秋荷完成签到,获得积分10
6秒前
linglingling完成签到 ,获得积分10
6秒前
科研通AI6.3的应助被邵蹦蹦采纳,获得10
7秒前
7秒前
Cong完成签到,获得积分10
7秒前
xbnie完成签到,获得积分10
8秒前
阳阳秋完成签到,获得积分10
10秒前
11秒前
GUAN发布了新的文献求助10
11秒前
Lucas的应助被你真是那个啊采纳,获得10
11秒前
12秒前
努力加油干的小猫咪完成签到 ,获得积分10
12秒前
福yyy发布了新的文献求助10
15秒前
jianghuren发布了新的文献求助10
16秒前
Zz发布了新的文献求助10
17秒前
zxzx发布了新的文献求助10
19秒前
horse完成签到,获得积分10
19秒前
TOT完成签到,获得积分10
20秒前
天天快乐的应助被绪绪采纳,获得10
20秒前
21秒前
23秒前
23秒前
lila完成签到,获得积分10
26秒前
26秒前
26秒前
26秒前
浮生发布了新的文献求助20
27秒前
trx发布了新的文献求助10
27秒前
csy完成签到,获得积分10
28秒前
科目三的应助被孟庆亮采纳,获得10
28秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186750
求助须知:如何正确求助?哪些是违规求助? 9575027
关于积分的说明 21839240
捐赠科研通 7784331
什么是DOI,文献DOI怎么找? 3434808
关于科研通互助平台的介绍 2559206
邀请新用户注册赠送积分活动 2481611